IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q1 Balance Sheet

Balance Sheet

As of 2026-03-31

Swipe to see the full flow
IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q1 Balance SheetBalance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.Current liabilities$1.30 BLiabilities$1.83 BNon-current liabilities$529.54 MEquity$1.56 BCurrent assets$1.45 BGross equity(calculated)$8.55 BAssets$3.39 BNon-current assets$1.93 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAccounts receivable, netInventoriesOther current assetsCash and cash equivalentsProperty and equipment, netOther long-term assetsGoodwillOperating lease right-of-use assetsIntangible assets, netCredit facilityAccrued liabilitiesCurrent portion of long-term debtAccounts payableCurrent portion of deferred revenueLong-term debt, net of current portionLong-term operating lease liabilities, net of current portionOther long-term liabilitiesDeferred income tax liabilitiesLong-term deferred revenue, net of current portionRetained earningsAdditional paid-in capitalCommon stock, $0.10 par value: Authorized: 120,000 shares; Issued: 108,500 shares in 2026 and 108,369 shares in 2025; Outstanding: 79,240 shares in 2026 and 79,712 shares in 2025Deferred stock units: Outstanding: 60 units in 2026 and 59 units in 2025Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stock, at cost: 29,261 shares in 2026 and 28,657 shares in 2025Accumulated other comprehensive lossCurrent liabilitiesCurrent liabilities$1.30 BCredit facilityCredit facility$530.00 MAccrued liabilitiesAccrued liabilities$453.55 MLiabilitiesLiabilities$1.83 BCurrent portion of long-term debtCurrent portion of long-term debt$150.00 MAccounts payableAccounts payable$129.97 MCurrent portion of deferred revenueCurrent portion of deferred revenue$36.33 MLong-term debt, net of current portionLong-term debt, net of current portion$299.85 MNon-current liabilitiesNon-current liabilities$529.54 MLong-term operating lease liabilities, net of current portionLong-term operating lease liabilities, net$98.75 MOther long-term liabilitiesOther long-term liabilities$54.03 MDeferred income tax liabilitiesDeferred income tax liabilities$44.60 MEquityEquity$1.56 BLong-term deferred revenue, net of current portionLong-term deferred revenue, net of current portion$32.31 MCurrent assetsCurrent assets$1.45 BGross equity (calculated)Gross equity(calculated)$8.55 BAccounts receivable, netAccounts receivable, net$603.54 MAssetsAssets$3.39 BInventoriesInventories$382.40 MOther current assetsOther current assets$267.60 MCash and cash equivalentsCash and cash equivalents$200.53 MNon-current assetsNon-current assets$1.93 BProperty and equipment, netProperty and equipment, net$740.38 MOther long-term assetsOther long-term assets$552.79 MRetained earningsRetained earnings$6.67 BGoodwillGoodwill$412.10 MOperating lease right-of-use assetsOperating lease right-of-use assets$121.40 MIntangible assets, netIntangible assets, net$104.75 MAdditional paid-in capitalAdditional paid-in capital$1.86 BCommon stock, $0.10 par value: Authorized: 120,000 shares; Issued: 108,500 shares in 2026 and 108,369 shares in 2025; Outstanding: 79,240 shares in 2026 and 79,712 shares in 2025Common stock$10.85 MDeferred stock units: Outstanding: 60 units in 2026 and 59 units in 2025Deferred stock units: Outstanding:60 units in 2026 and 59 units in 2025$6.17 MTreasury stock, at cost: 29,261 shares in 2026 and 28,657 shares in 2025Treasury stock−$6.93 BAccumulated other comprehensive lossAccumulated other comprehensive loss−$64.94 M
Chart details

IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q1 Balance Sheet

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

Assets
3,385,497,000 US dollars
Current assets
1,454,075,000 US dollars
Non-current assets
1,931,422,000 US dollars
Liabilities
1,829,394,000 US dollars
Current liabilities
1,299,851,000 US dollars
Non-current liabilities
529,543,000 US dollars
Equity
1,556,103,000 US dollars
Accounts receivable, net
603,544,000 US dollars
Inventories
382,400,000 US dollars
Other current assets
267,603,000 US dollars
Cash and cash equivalents
200,528,000 US dollars
Property and equipment, net
740,382,000 US dollars
Other long-term assets
552,791,000 US dollars
Goodwill
412,104,000 US dollars
Operating lease right-of-use assets
121,395,000 US dollars
Intangible assets, net
104,750,000 US dollars
Credit facility
530,000,000 US dollars
Accrued liabilities
453,552,000 US dollars
Current portion of long-term debt
149,997,000 US dollars
Accounts payable
129,974,000 US dollars
Current portion of deferred revenue
36,328,000 US dollars
Long-term debt, net of current portion
299,854,000 US dollars
Long-term operating lease liabilities, net of current portion
98,747,000 US dollars
Other long-term liabilities
54,034,000 US dollars
Deferred income tax liabilities
44,595,000 US dollars
Long-term deferred revenue, net of current portion
32,313,000 US dollars
Retained earnings
6,670,348,000 US dollars
Additional paid-in capital
1,861,079,000 US dollars
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 108,500 shares in 2026 and 108,369 shares in 2025; Outstanding: 79,240 shares in 2026 and 79,712 shares in 2025
10,850,000 US dollars
Deferred stock units: Outstanding: 60 units in 2026 and 59 units in 2025
6,169,000 US dollars
Treasury stock, at cost: 29,261 shares in 2026 and 28,657 shares in 2025
negative 6,927,403,000 US dollars
Accumulated other comprehensive loss
negative 64,940,000 US dollars
Gross equity (calculated)
8,548,446,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q1 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!